3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 3
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
3
Carcinoma, Non-Small-Cell Lung
2
Thoracic Neoplasms
1
Primary Breast Cancer
1
Patient Acceptance of Health Care
1
Non-small Cell Lung Cancer Metastatic
1
Lung Neoplasms
1
Lung Diseases
1
Interventions
Carboplatin
2
Vinorelbine
1
Pemetrexed
1
Paclitaxel
1
Nivolumab
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Thoracic Neoplasms
×
Vinorelbine
×
Clear all
NCT05583188
2024-07-19
VIGOR
Galvanize Therapeutics, Inc.
Phase 4
Terminated
5 enrolled